Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rate control therapy in permanent atrial fibrillation: digoxin vs bisoprolol
2015-005043-13Phase 4Completed
- Sponsor
- University of Birmingham
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) comparing Digoxin arm with Bisoprolol arm (2 arms). Primary endpoint: SF-36 physical component summary at six months. Started Aug 2016; status: completed.
02
Drugs
digoxinbisoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2015-005043-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005043-13.